304
Participants
Start Date
April 22, 2022
Primary Completion Date
April 20, 2023
Study Completion Date
May 17, 2023
Monad 1
Single therapy cream containing Lidocaine. Lidocaine is a topical anesthetic.
Monad 2
Single therapy cream containing Halobetasol Propionate (low-strength). HPB is a topical corticosteroid.
Monad 3
Single therapy cream containing Halobetasol Propionate (high strength).
Combination - CITI-002 (low dose)
Combination cream containing Lidocaine and HBP (low)
Combination - CITI-002 (high dose)
Combination cream containing Lidocaine and HBP (high)
Site #04, Harrisburg
Site #05, West Palm Beach
Site #01, Huntsville
Site #14, Gulfport
Site #11, Mentor
Site #02, Wyoming
Site #08, Omaha
Site #10, Covington
Site #12, Prairieville
Site #13, Tulsa
Site #15, McKinney
Site #07, Tucson
Site #09, Pomona
Site #06, Chula Vista
Site #16, San Diego
Site #03, San Diego
Lead Sponsor
Therapeutics, Inc.
INDUSTRY
Citius Pharmaceuticals, Inc.
INDUSTRY